Northern Trust Corp Neuro Pace Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Neuro Pace Inc stock. As of the latest transaction made, Northern Trust Corp holds 159,812 shares of NPCE stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,812

Previous 42,165 279.02%

Holding current value

$1.84 Million

Previous $318,000 250.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.65 - $8.46 $782,352 - $995,293	117,647 Added 279.02%	159,812 $1.11 Million
Q2 2024 Aug 14, 2024	BUY	$6.38 - $15.33 $80,202 - $192,713	12,571 Added 42.48%	42,165 $318,000
Q1 2024 May 14, 2024	SELL	$9.78 - $17.5 $53,085 - $94,990	-5,428 Reduced 15.5%	29,594 $390,000
Q4 2023 Feb 13, 2024	BUY	$5.9 - $10.31 $75,643 - $132,184	12,821 Added 57.75%	35,022 $361,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $9.73 $24,380 - $59,304	6,095 Added 37.84%	22,201 $216,000
Q2 2023 Aug 11, 2023	SELL	$3.98 - $5.12 $258 - $332	-65 Reduced 0.4%	16,106 $72,000
Q3 2022 Nov 14, 2022	BUY	$3.1 - $5.98 $15,177 - $29,278	4,896 Added 43.42%	16,171 $61,000
Q2 2022 Aug 12, 2022	SELL	$4.95 - $8.7 $242,099 - $425,508	-48,909 Reduced 81.27%	11,275 $56,000
Q1 2022 May 13, 2022	SELL	$7.06 - $11.57 $30,661 - $50,248	-4,343 Reduced 6.73%	60,184 $494,000
Q4 2021 Feb 08, 2022	SELL	$8.63 - $17.36 $7,352 - $14,790	-852 Reduced 1.3%	64,527 $650,000
Q3 2021 Nov 15, 2021	SELL	$15.85 - $25.07 $93,483 - $147,862	-5,898 Reduced 8.27%	65,379 $1.04 Million
Q2 2021 Aug 13, 2021	BUY	$19.03 - $26.5 $1.36 Million - $1.89 Million	71,277 New	71,277 $1.7 Million

Others Institutions Holding NPCE

# of Institutions

Shares Held

21.3M

Call Options Held

1.3K

Put Options Held

100

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $286M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Neuro Pace Inc Transaction History